S.A. REVERTE PRODUCTOS MINERALES – Trademark Portfolio

Entity Type: 03

S.A. REVERTE PRODUCTOS MINERALES holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 5 filings in this category. Currently, 5 trademarks are registered. Notable registered marks include CALCIPORE, GRANIFORT, NUTRIPURE-CALCIUM, REVERTÉ FOOD AND PHARMA, and REVERTÉ MINERALS AMERICA. The owner is based in Barcelona.

Afores, s/n

Castellet I La Gornal

Barcelona 08729 , ES

5 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

S.A. REVERTE PRODUCTOS MINERALES's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

1
Chemicals (5 filings)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

Frequently Asked Questions

How many trademarks does S.A. REVERTE PRODUCTOS MINERALES have?

S.A. REVERTE PRODUCTOS MINERALES has 5 U.S. trademarks filed with the USPTO. Of these, 5 registered.

What trademark classes does S.A. REVERTE PRODUCTOS MINERALES file in?

S.A. REVERTE PRODUCTOS MINERALES files trademarks across 1 Nice Classification class. The most active classes are Class 1 (Chemicals). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.

What are S.A. REVERTE PRODUCTOS MINERALES's most well-known trademarks?

S.A. REVERTE PRODUCTOS MINERALES's registered trademark portfolio includes well-known marks such as CALCIPORE, GRANIFORT, NUTRIPURE-CALCIUM, REVERTÉ FOOD AND PHARMA, and REVERTÉ MINERALS AMERICA. These are among 5 currently registered trademarks in the portfolio.

What is S.A. REVERTE PRODUCTOS MINERALES's trademark registration success rate?

S.A. REVERTE PRODUCTOS MINERALES has a 100% trademark registration rate, with 5 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.